Study of Cyclosporine Ophthalmic Soution Group and Cyclosporine Ophthalmic Suspension Group

Clinical trial NCT01768312 · COMPLETED

Trial details

NCT number: NCT01768312
Sponsor: Hanlim Pharm. Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Dry Eye Syndromes

Start date: 2012-08-23
Primary completion: 2013-07-31
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.